Paul E. Tornambe, MD, FACS
Founder and President
The physicians at Retina Consultants San Diego are nationally recognized leaders in their field. They participate in most clinical trials assessing new therapies for macular degeneration, diabetic retinopathy, as well as other retinal diseases. In addition to its clinical services, Retina Consultants San Diego provides continuing education and consulting services to the local, national, and international ophthalmic communities and other healthcare industries.
Here at Retina Consultants San Diego, we use state-of-the-art diagnostic and therapeutic technology, including wide-field fluorescein photography and angiography, ICG angiography, autofluorescence, ultrasonography, and spectral-domain optical coherence tomography with enhanced depth imaging.
Each doctor in our group is board certified in ophthalmology and has completed formal subspecialty training in medical and surgical diseases of the retina, vitreous, and macula. Each member is nationally recognized for their participation in research and educational programs primarily aimed at understanding the causes of retinal diseases and developing novel treatments. For each of our esteemed doctors, a brief biographical sketch is provided.What Makes Us Different?
Intravitreal drug delivery has become a popular method of treatment of many retinal diseases, commonly including AMD, Diabetic Retinopathy, and Retinal Vein Occlusions. The frequency of intravitreal injections has significantly increased since the introduction of Anti-VEGF medications. This is an important procedure that Retina Specialists use on a daily basis, and it is important to master the techniques of effective injections for patient safety and reduction of complications.More info
Diabetic retinopathy, the most common diabetic eye disease, occurs when blood vessels in the retina change. Sometimes these vessels swell and leak fluid or even close off completely. In other cases, abnormal new blood vessels grow on the surface of the retina.Watch Dr. Tornambe's video on diabetes
Age-related macular degeneration (AMD) is a deterioration or breakdown of the eye's macula. The macula is a small area in the retina — the light-sensitive tissue lining the back of the eye. The macula is the part of the retina that is responsible for your central vision, allowing you to see fine details clearly.Watch Dr. Tornambe's video on AMD
Central retinal vein occlusion (CRVO) is a blockage of the main vein in the retina. (Blockage of the small veins in the retina is called branch retinal vein occlusion, or BRVO.) The blockage causes the walls of the vein to leak blood and excess fluid into the retina. When this fluid collects in the macula (the area of the retina responsible for central vision), vision becomes blurry.More info
In central serous retinopathy (sometimes called central serous choroidopathy), fluid builds up under the retina and distorts vision. Fluid leakage is believed to come from a tissue layer with blood vessels under the retina, called the choroid. Another layer of cells called the retinal pigment epithelium (RPE) is responsible for preventing fluid from leaking from the choroid under the retina. When, for unknown reasons, tiny areas of the RPE become defective, fluid builds up and accumulates under the RPE, much as liquid in a blister collects under the skin. As a result, a small detachment forms under the retina, causing vision to become distorted.More info
Macular edema is swelling or thickening of the eye's macula, the part of your eye responsible for detailed, central vision.More info
A macular hole is a small break in the macula, the part of your eye responsible for detailed, central vision.More info
A macular pucker (also called an epiretinal membrane) is a layer of scar tissue that grows on the surface of the retina, particularly the macula, which is the part of your eye responsible for detailed, central vision.More info
As the eye ages the vitreous gel that fills it shrinks. Usually the vitreous moves away from the retina without causing problems. But sometimes the vitreous pulls hard enough to tear the retina in one or more places. Fluid may pass through a retinal tear, lifting the retina off the back of the eye — much as wallpaper can peel off a wall. When the retina is pulled away from the back of the eye like this, it is called a retinal detachment.More info
Vitrectomy is the surgical removal of the vitreous gel from the middle of the eye.More info
This treatment to repair a retinal detachment involves placing a flexible band (scleral buckle) around the eye to counteract the force pulling the retina out of place. The ophthalmologist often drains the fluid under the detached retina, allowing the retina to settle back into its normal position against the back wall of the eye. This procedure is performed in an operating room.Watch Interview with Dr. Tornambe on Scleral Buckling
In this procedure, a gas bubble is injected into the vitreous space inside the eye in combination with laser surgery or cryotherapy. The gas bubble pushes the retinal tear into place against the back wall of the eye. Sometimes this procedure can be done in the ophthalmologist’s office. Your ophthalmologist will ask you to constantly maintain a certain head position for several days. The gas bubble will gradually disappear.Video on Pneumatic Retinopexy by Dr. Tornambe
Optical coherence tomography (OCT) is a non-invasive imaging test that uses light waves to take cross-section pictures of your retina, the light-sensitive tissue lining the back of the eye.More info
Fluorescein angiography is an eye test that uses a special dye and camera to look at blood flow in the retina and choroid, the two layers in the back of the eye.More info
Indocyanine green angiography is a diagnostic test that involves taking photographs of the blood vessels in the eye with the help of a contrast dye. Indocyanine is a green dye that works with infrared light and is visualized with a special camera. The images produced by this test help doctors evaluate the retina and diagnose or monitor problems such as macular degeneration, abnormal vessel growth, macular edema, certain types of retinal detachment, and tumors.
This exciting new technology (referred to as OCT-A) allows us to do an angiogram of the retinal circulation without an injection, and without a dye by imaging the moving cells in your blood stream. It uses light, not radiation, has no side effects, and is performed in about a minute per eye. It is particularly helpful in managing age related macular degeneration, diabetes, and vascular occlusions. In our opinion, it will help customize care for a specific patient situation, perhaps decrease the injection frequency or indicate when an injection is needed earlier than normally expected, and help us determine if the drug we are using is the most effective drug for this patient's individual problem. Although the other dye based angiograms will be needed at times, we feel OCT-A will replace a majority of dye based angiograms.
Dietary flavanoids that protect retinal cells from injury and death, macular degeneration
All of our doctors were trained at outstanding institutions including Washington University in St. Louis, Wills Eye Hospital in Philadelphia, Johns Hopkins Wilmer Eye Institute and Duke University Eye Center. There is no substitute for training and experience.
Our physicians utilize the most advanced therapies and surgical approaches, combined with an unfailing attention to consistency and detail, to provide the best treatment available.
All of our offices have the latest diagnostic and therapeutic services. We keep our patients Informed - by providing information on common diseases in print and on our website. We serve as a regional leader for large-scale clinical trials, providing access to next generation therapies.
Our doctors treat their patients like family members and take as much time as needed to explain their disease. We work hard to keep visit durations to a minimum.
Our offices are easy to find, with multiple locations. We participate with most insurance plans.
We participate with most insurance plans.